RCDTF
Price
$65.44
Change
+$9.40 (+16.77%)
Updated
Jun 13 closing price
Capitalization
10.63B
VRBCF
Price
$346.00
Change
+$22.00 (+6.79%)
Updated
May 22 closing price
Capitalization
2.61B
Interact to see
Advertisement

RCDTF vs VRBCF

Header iconRCDTF vs VRBCF Comparison
Open Charts RCDTF vs VRBCFBanner chart's image
Recordati Industria Chimica e Farmaceutica S.p.A
Price$65.44
Change+$9.40 (+16.77%)
Volume$300
Capitalization10.63B
Virbac SA
Price$346.00
Change+$22.00 (+6.79%)
Volume$23
Capitalization2.61B
RCDTF vs VRBCF Comparison Chart in %
Loading...
RCDTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRBCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RCDTF vs. VRBCF commentary
Jul 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RCDTF is a Hold and VRBCF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 17, 2025
Stock price -- (RCDTF: $65.44 vs. VRBCF: $346.00)
Brand notoriety: RCDTF and VRBCF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: RCDTF: 115% vs. VRBCF: 114%
Market capitalization -- RCDTF: $10.63B vs. VRBCF: $2.61B
RCDTF [@Pharmaceuticals: Major] is valued at $10.63B. VRBCF’s [@Pharmaceuticals: Major] market capitalization is $2.61B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RCDTF’s FA Score shows that 1 FA rating(s) are green whileVRBCF’s FA Score has 0 green FA rating(s).

  • RCDTF’s FA Score: 1 green, 4 red.
  • VRBCF’s FA Score: 0 green, 5 red.
According to our system of comparison, RCDTF is a better buy in the long-term than VRBCF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RCDTF’s TA Score shows that 2 TA indicator(s) are bullish while VRBCF’s TA Score has 2 bullish TA indicator(s).

  • RCDTF’s TA Score: 2 bullish, 1 bearish.
  • VRBCF’s TA Score: 2 bullish, 1 bearish.
According to our system of comparison, both RCDTF and VRBCF are a good buy in the short-term.

Price Growth

RCDTF (@Pharmaceuticals: Major) experienced а 0.00% price change this week, while VRBCF (@Pharmaceuticals: Major) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.47%. For the same industry, the average monthly price growth was +1.27%, and the average quarterly price growth was +11.07%.

Industries' Descriptions

@Pharmaceuticals: Major (+1.47% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCDTF($10.6B) has a higher market cap than VRBCF($2.61B). VRBCF has higher P/E ratio than RCDTF: VRBCF (29.33) vs RCDTF (26.11). RCDTF YTD gains are higher at: 17.825 vs. VRBCF (1.996). RCDTF has higher annual earnings (EBITDA): 615M vs. VRBCF (213M). RCDTF has more cash in the bank: 231M vs. VRBCF (176M). VRBCF has less debt than RCDTF: VRBCF (148M) vs RCDTF (1.58B). RCDTF has higher revenues than VRBCF: RCDTF (1.99B) vs VRBCF (1.15B).
RCDTFVRBCFRCDTF / VRBCF
Capitalization10.6B2.61B407%
EBITDA615M213M289%
Gain YTD17.8251.996893%
P/E Ratio26.1129.3389%
Revenue1.99B1.15B172%
Total Cash231M176M131%
Total Debt1.58B148M1,068%
FUNDAMENTALS RATINGS
RCDTF vs VRBCF: Fundamental Ratings
RCDTF
VRBCF
OUTLOOK RATING
1..100
4946
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
5650
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4457
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RCDTF's Valuation (50) in the null industry is in the same range as VRBCF (50). This means that RCDTF’s stock grew similarly to VRBCF’s over the last 12 months.

VRBCF's Profit vs Risk Rating (50) in the null industry is in the same range as RCDTF (56). This means that VRBCF’s stock grew similarly to RCDTF’s over the last 12 months.

VRBCF's SMR Rating (100) in the null industry is in the same range as RCDTF (100). This means that VRBCF’s stock grew similarly to RCDTF’s over the last 12 months.

RCDTF's Price Growth Rating (44) in the null industry is in the same range as VRBCF (57). This means that RCDTF’s stock grew similarly to VRBCF’s over the last 12 months.

RCDTF's P/E Growth Rating (100) in the null industry is in the same range as VRBCF (100). This means that RCDTF’s stock grew similarly to VRBCF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RCDTFVRBCF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
7%
Bullish Trend 6 days ago
27%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
7%
Bearish Trend 2 days ago
25%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
19%
Bullish Trend 2 days ago
16%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
18%
Bullish Trend 2 days ago
17%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
8%
Bullish Trend 2 days ago
20%
View a ticker or compare two or three
Interact to see
Advertisement
RCDTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRBCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CNXT29.780.49
+1.67%
VanEck ChiNext ETF
BKEM67.210.54
+0.81%
BNY Mellon Emerging Markets Equity ETF
BUFY20.92-0.10
-0.45%
FT Vest Laddered Intl Mod Buffr ETF
DIHP29.07-0.32
-1.07%
Dimensional International High Pbly ETF
VLU193.18-2.20
-1.13%
SPDR® S&P 1500 Value Tilt ETF

RCDTF and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCDTF has been loosely correlated with VRBCF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if RCDTF jumps, then VRBCF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCDTF
1D Price
Change %
RCDTF100%
N/A
VRBCF - RCDTF
56%
Loosely correlated
N/A
RHHBF - RCDTF
3%
Poorly correlated
N/A
RHHBY - RCDTF
2%
Poorly correlated
-1.61%
PTKFY - RCDTF
0%
Poorly correlated
N/A
PTKFF - RCDTF
0%
Poorly correlated
N/A
More

VRBCF and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRBCF has been loosely correlated with RCDTF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if VRBCF jumps, then RCDTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRBCF
1D Price
Change %
VRBCF100%
N/A
RCDTF - VRBCF
56%
Loosely correlated
N/A
OGN - VRBCF
1%
Poorly correlated
-2.55%
MIRA - VRBCF
1%
Poorly correlated
+7.79%
CSWYF - VRBCF
0%
Poorly correlated
N/A
JCRRF - VRBCF
-0%
Poorly correlated
N/A
More